跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,918 条关于
“CD137/4-1BB”
全部
19,918
临床试验
7,849
药物
4,687
机构
1,603
资讯
5,779
7个月前
Ankyra Therapeutics Unveils First-in-Class CD137-Anchored Immunotherapy ANK-203 with Promising Preclinical Anti-Tumor Activity
3年前
invoX Pharma Completes $161 Million Acquisition of F-star Therapeutics to Strengthen Bispecific Antibody Pipeline
去年
Compass Therapeutics' CTX-471 Shows Promise with NCAM Biomarker Correlation in Advanced Malignancies
3个月前
Soft Tissue Sarcoma Pipeline Gains Momentum: 70+ Companies Advance 75+ Therapies Across All Development Stages
2年前
CD137-Targeted Therapies Show Promise in Cancer Immunotherapy
去年
Esophageal Cancer Pipeline Shows Promise with 100+ Therapies in Development Across 80+ Companies
10个月前
ModeX Therapeutics Initiates First-in-Class Trispecific Antibody Trial for Advanced Cancers
2年前
Hanmi Pharmaceutical Partners with MSD to Test Novel Bispecific Antibody BH3120 in Combination with KEYTRUDA
3年前
Givastomig Demonstrates Anti-Tumor Activity in Gastric Cancer via Targeted T-Cell Activation
去年
Dual Targeting PD-L1 and 4-1BB Overcomes Lenalidomide Resistance in Follicular Lymphoma
第 1 页,共 578 页
上一页
下一页